Prophylactic mitomycin C to inhibit corneal haze after photorefractive keratectomy for residual myopia following radial keratotomy
PURPOSE: To evaluate the efficacy and safety of mitomycin C (MMC) 0.02% in inhibiting haze formation after excimer laser photorefractive keratectomy (PRK) for residual myopia following radial keratotomy (RK).
METHODS: A prospective, nonrandomized, noncomparative interventional case series was conducted of 22 eyes (14 patients) with residual myopia after RK performed at a single institution. All eyes were treated with PRK and a single intraoperative topical application of MMC 0.02% solution for 2 minutes using a soaked cellulose sponge placed over the ablated area. Refraction, uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), and slit-lamp evidence of cotneal opacity (haze) were evaluated over 12 months.
RESULTS: Twelve months postoperatively, 3 eyes showed grade 1 haze, and 2 eyes showed grade 0.5 haze. Twelve months postoperatively, 2 (9%) eyes had UCVA > or = 20/20. No eye before and 17 (77%) eyes after treatment had UCVA > or = 20/40, and no eye before and 9 eyes (40.9%) after treatment had UCVA > or = 20/25. Best spectacle-corrected visual acuity was > or = 20/40 in all (100%) eyes and 21 (95%) eyes before and after treatment, respectively, and > or = 20/25 in 12 (54.5%) eyes before and after treatment. One (4.5%) eye lost 1 line of BSCVA. Mean spherical equivalent refraction achieved was -0.18 diopters (D) (range: -0.75 to +0.50 D) compared to -2.72 D (range: -1.50 to -4.00 D) before treatment. Twelve months after treatment, 19 (85.5%) eyes had a refractive outcome within +/- 0.50 D.
CONCLUSIONS: A single intraoperative application of MMC 0.02% for 2 minutes appears to be effective in preventing subepithelial haze after PRK for residual myopia in patients with undercorrection or regression following RK.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2007 |
|---|---|
| Erschienen: |
2007 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Journal of refractive surgery (Thorofare, N.J. : 1995) - 23(2007), 3 vom: 07. März, Seite 226-32 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nassaralla, Belquiz A [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 19.04.2007 Date Revised 10.02.2022 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM169212203 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM169212203 | ||
| 003 | DE-627 | ||
| 005 | 20231223120839.0 | ||
| 007 | tu | ||
| 008 | 231223s2007 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0564.xml |
| 035 | |a (DE-627)NLM169212203 | ||
| 035 | |a (NLM)17385287 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nassaralla, Belquiz A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prophylactic mitomycin C to inhibit corneal haze after photorefractive keratectomy for residual myopia following radial keratotomy |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 19.04.2007 | ||
| 500 | |a Date Revised 10.02.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a PURPOSE: To evaluate the efficacy and safety of mitomycin C (MMC) 0.02% in inhibiting haze formation after excimer laser photorefractive keratectomy (PRK) for residual myopia following radial keratotomy (RK) | ||
| 520 | |a METHODS: A prospective, nonrandomized, noncomparative interventional case series was conducted of 22 eyes (14 patients) with residual myopia after RK performed at a single institution. All eyes were treated with PRK and a single intraoperative topical application of MMC 0.02% solution for 2 minutes using a soaked cellulose sponge placed over the ablated area. Refraction, uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), and slit-lamp evidence of cotneal opacity (haze) were evaluated over 12 months | ||
| 520 | |a RESULTS: Twelve months postoperatively, 3 eyes showed grade 1 haze, and 2 eyes showed grade 0.5 haze. Twelve months postoperatively, 2 (9%) eyes had UCVA > or = 20/20. No eye before and 17 (77%) eyes after treatment had UCVA > or = 20/40, and no eye before and 9 eyes (40.9%) after treatment had UCVA > or = 20/25. Best spectacle-corrected visual acuity was > or = 20/40 in all (100%) eyes and 21 (95%) eyes before and after treatment, respectively, and > or = 20/25 in 12 (54.5%) eyes before and after treatment. One (4.5%) eye lost 1 line of BSCVA. Mean spherical equivalent refraction achieved was -0.18 diopters (D) (range: -0.75 to +0.50 D) compared to -2.72 D (range: -1.50 to -4.00 D) before treatment. Twelve months after treatment, 19 (85.5%) eyes had a refractive outcome within +/- 0.50 D | ||
| 520 | |a CONCLUSIONS: A single intraoperative application of MMC 0.02% for 2 minutes appears to be effective in preventing subepithelial haze after PRK for residual myopia in patients with undercorrection or regression following RK | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Alkylating Agents |2 NLM | |
| 650 | 7 | |a Mitomycin |2 NLM | |
| 650 | 7 | |a 50SG953SK6 |2 NLM | |
| 700 | 1 | |a McLeod, Stephen D |e verfasserin |4 aut | |
| 700 | 1 | |a Nassaralla, João J |c Jr |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of refractive surgery (Thorofare, N.J. : 1995) |d 1998 |g 23(2007), 3 vom: 07. März, Seite 226-32 |w (DE-627)NLM074736620 |x 1081-597X |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2007 |g number:3 |g day:07 |g month:03 |g pages:226-32 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2007 |e 3 |b 07 |c 03 |h 226-32 | ||